Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anna Bulek"'
Autor:
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R. Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew Sewell, Paul Maciocia, Shimobi Onuoha, Martin Pule
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Peripheral T cell lymphomas are typically aggressive with a poor prognosis. Unlike other hematologic malignancies, the lack of target antigens to discriminate healthy from malignant cells limits the efficacy of immunotherapeutic approaches.
Externí odkaz:
https://doaj.org/article/0a0cba1c19b24f4e8e75069f7a2b0924
Autor:
Julia Taylor, Anna Bulek, Isaac Gannon, Mathew Robson, Evangelia Kokalaki, Thomas Grothier, Callum McKenzie, Mohamed El-Kholy, Maria Stavrou, Charlotte Traynor-White, Wen Chean Lim, Panagiota Panagiotou, Saket Srivastava, Vania Baldan, James Sillibourne, Mathieu Ferrari, Martin Pule, Simon Thomas
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
SHP1 and SHP2 are SH2 domain-containing proteins which have inhibitory phosphatase activity when recruited to phosphorylated ITIMs and ITSMs on inhibitory immune receptors. Consequently, SHP1 and SHP2 are key proteins in the transmission of inhibitor
Externí odkaz:
https://doaj.org/article/e38d52e6c99944609c3459b7f08fd187
Autor:
Evangelia Kokalaki, Biao Ma, Mathieu Ferrari, Thomas Grothier, Warren Hazelton, Somayya Manzoor, Eren Costu, Julia Taylor, Anna Bulek, Saket Srivastava, Isaac Gannon, Ram Jha, Rosalind Gealy, Lukas Stanczuk, Tatiana Rizou, Mathew Robson, Mohamed El-Kholy, Vania Baldan, Matteo Righi, James Sillibourne, Simon Thomas, Shimobi Onuoha, Shaun Cordoba, Martin Pule
Publikováno v:
Molecular Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7569568c73a33662c465b418886f9290
https://doi.org/10.1016/j.ymthe.2023.03.020
https://doi.org/10.1016/j.ymthe.2023.03.020
Autor:
Mathieu Ferrari, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alex Kinna, Biao Ma, Reyisa Bugda, Zulaikha Akbar, Saket Srivast, Priyankha Ghongane, Isaac Gannon, Matthew Robson, James Sillibourne, Ram Jha, Wen Chean Lim, Jade Hopkins, Martin Welin, Sachin Surade, Michael Dyson, John McCafferty, Shaun Cordoba, Simon Thomas, Derek Logan, Andy Sewell, Paul Maciocia, Shimobi Onuoha, Martin Pule
Peripheral T cell lymphomas are typically aggressive with a poor prognosis. Unlike other hematologic malignancies, the lack of target antigens to discriminate healthy from malignant cells has limited the efficacy of immunotherapeutic approaches. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bb26831952ccaeec228571bdbf82da9
https://doi.org/10.21203/rs.3.rs-1475171/v1
https://doi.org/10.21203/rs.3.rs-1475171/v1
Autor:
Florian, Madura, Pierre J, Rizkallah, Mateusz, Legut, Christopher J, Holland, Anna, Fuller, Anna, Bulek, Andrea J, Schauenburg, Andrew, Trimby, Jade R, Hopkins, Stephen A, Wells, Andrew, Godkin, John J, Miles, Malkit, Sami, Yi, Li, Nathaniel, Liddy, Bent K, Jakobsen, E Joel, Loveridge, David K, Cole, Andrew K, Sewell
Publikováno v:
European Journal of Immunology
The HLA‐A*02:01‐restricted decapeptide EAAGIGILTV, derived from melanoma antigen recognized by T‐cells‐1 (MART‐1) protein, represents one of the best‐studied tumor associated T‐cell epitopes, but clinical results targeting this peptide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4cdfe2ebbf2aa64cc7714dc26e19d1ee
https://pubmed.ncbi.nlm.nih.gov/31091334
https://pubmed.ncbi.nlm.nih.gov/31091334
Autor:
Florian, Madura, Pierre J, Rizkallah, Christopher J, Holland, Anna, Fuller, Anna, Bulek, Andrew J, Godkin, Andrea J, Schauenburg, David K, Cole, Andrew K, Sewell
Publikováno v:
European Journal of Immunology
Although it has been shown that human tumor-associated, HLA anchor residue modified "heteroclitic" peptides may induce stronger immune responses than wild-type peptides in cancer vaccine trials, it has also been shown that some T cells primed with th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c654c7e9c53eccf88358e19a035b622c
http://europepmc.org/articles/PMC4357396
http://europepmc.org/articles/PMC4357396
Autor:
Valentina, Bianchi, Anna, Bulek, Anna, Fuller, Angharad, Lloyd, Meriem, Attaf, Pierre J, Rizkallah, Garry, Dolton, Andrew K, Sewell, David K, Cole
Publikováno v:
The Journal of Biological Chemistry
Human CD8(+) cytotoxic T lymphocytes can mediate tumor regression in melanoma through the specific recognition of HLA-restricted peptides. Because of the relatively weak affinity of most anti-cancer T-cell receptors (TCRs), there is growing emphasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6b6681f420d198bb5070dcc4eb69dcc2
https://pubmed.ncbi.nlm.nih.gov/26917722
https://pubmed.ncbi.nlm.nih.gov/26917722